Chemosuppression of breast cancer with long-term tamoxifen therapy
- 31 January 1991
- journal article
- review article
- Published by Elsevier in Preventive Medicine
- Vol. 20 (1) , 3-14
- https://doi.org/10.1016/0091-7435(91)90002-l
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Tamoxifen therapy in primary breast cancer: biology, efficacy, and side effects.Journal of Clinical Oncology, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.Journal of Clinical Oncology, 1986
- Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.Journal of Clinical Oncology, 1986
- The pharmacology and clinical uses of tamoxifenPharmacology & Therapeutics, 1984
- Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose LevelsBMJ, 1973
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967
- Contrasting Endocrine Activities of cis and trans Isomers in a Series of Substituted TriphenylethylenesNature, 1966
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896